⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 1, 2024

Figures S1 through S19 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER⁺ Breast Cancer

Anran Chen Beom-Jun Kim Aparna Mitra Craig T. Vollert Jonathan T. Lei Diana Fandino Meenakshi Anurag Matthew V. Holt Xuxu Gou Jacob B. Pilcher Matthew P. Goetz Donald W. Northfelt Susan G. Hilsenbeck C. Gary Marshall Marc L. Hyer Robert Papp Shou-Yun Yin Carmine De Angelis Rachel Schiff Suzanne A.W. Fuqua X. Cynthia Charles E. Foulds Matthew J. Ellis

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

This file contains 19 Supplementary Figures.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chen et al. (2024) studied this question.

synapsesocial.com/papers/68e56226e2b3180350efeee6 https://doi.org/10.1158/1535-7163.27142216

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S5 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER<sup>+</sup> Breast Cancer2024
2Figure S2 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER<sup>+</sup> Breast Cancer2024
3Figure S4 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER<sup>+</sup> Breast Cancer2024
4Figure S17 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER<sup>+</sup> Breast Cancer2024
5Figure S1 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER<sup>+</sup> Breast Cancer2024